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Split-hand/split-foot malformation (SHFM), a limb malformation involving the central rays of the autopod and
presenting with syndactyly, median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges,
metacarpals, and metatarsals, is phenotypically analogous to the naturally occurring murine Dactylaplasiamutant
(Dac). Results of recent studies have shown that, in heterozygous Dac embryos, the central segment of the apical
ectodermal ridge (AER) degenerates, leaving the anterior and posterior segments intact; this finding suggests that
localized failure of ridge maintenance activity is the fundamental developmental defect in Dac and, by inference,
in SHFM. Results of gene-targeting studies have demonstrated that p63, a homologue of the cell-cycle regulator
TP53, plays a critically important role in regulation of the formation and differentiation of the AER. Two missense
mutations, 724ArG, which predicts amino acid substitution K194E, and 982TrC, which predicts amino acid
substitution R280C, were identified in exons 5 and 7, respectively, of the p63 gene in two families with SHFM.
Two additional mutations (279RrH and 304RrQ) were identified in families with EEC (ectrodactyly, ectodermal
dysplasia, and facial cleft) syndrome. All four mutations are found in exons that fall within the DNA-binding
domain of p63. The two amino acids mutated in the families with SHFM appear to be primarily involved in
maintenance of the overall structure of the domain, in contrast to the p63mutations responsible for EEC syndrome,
which reside in amino acid residues that directly interact with the DNA.
Introduction
Split-hand/split-foot malformation (SHFM [MIM
183600]) is a limb malformation involving the central
rays of the autopod and presenting with syndactyly,
median clefts of the hands and feet, and aplasia and/or
hypoplasia of the phalanges, metacarpals, and metatar-
sals (McKusick 1994; Nunes et al. 1995; Crackower et
al. 1996; Gurrieri et al. 1996; Raas-Rothchild et al.
1996). There is phenotypic overlap with the EEC (ec-
trodactyly, ectodermal dysplasia, and facial cleft) syn-
drome [MIM 129900], in which distal limb malfor-
mations sometimes occur as part of the phenotypic
spectrum (Roelfsema and Cobben 1996). However, the
essential components of the EEC phenotype include not
only limb anomalies but also cleft lip and palate with
lacrimal duct atresia and defects of the skin, teeth, hair,
and nails (Gorlin et al. 1990). Another disorder, Ad-
ams-Oliver syndrome (AOS [MIM 100300]) (McKusick
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1994) has also been confused with SHFM and EEC. In
AOS, variable distal limb reduction abnormalities occur
in conjunction with defects of the calvarium and scalp.
In addition, ectrodactyly is a major but variable feature
of focal dermal hypoplasia (MIM 305600) (McKusick
1994). SHFM is phenotypically analogous to the natu-
rally occurring murine Dactylaplasia mutant (Dac)
(Chai 1981). Dac embryos initiate limb development
and outgrowth properly, but they fail to form a normal
autopod. The results of recent studies have shown that,
in heterozygous Dac embryos, the apical ectodermal
ridge (AER), a critical signaling center that directs the
outgrowth and patterning of the developing limb (Saun-
ders 1948), is morphologically normal at E10.5, but, by
E11.5, its central segment degenerates, leaving the an-
terior and posterior segments intact (Crackower et al.
1998). This suggests that localized failure of ridge main-
tenance activity is the fundamental developmental defect
in Dac and, by inference, in SHFM (Crackower et al.
1996).
Findings from recent gene-targeting studies have dem-
onstrated that p63, a homologue of the cell-cycle reg-
ulator TP53, plays a critically important role in regu-
lation of the formation and differentiation of the AER.
Mice lacking p63 have striking developmental defects,
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including partial or total limb truncations (amelia), ab-
normal skin, and absence of hair follicles, teeth, and
mammary glands (Mills et al. 1999; Yang et al. 1999).
The limb buds of p63/mice express little or no Fgf8,
and they lack a morphologically recognizable AER, sug-
gesting that the amelia observed in p63/ mice is the
result of failure of AER formation. This indicates that
p63 plays a central role in the initiation of the ridge.
Heterozygous mutations in the p63 gene were recently
reported in individuals affected with the EEC syndrome
(Celli et al. 1999).
Several reports have described individuals with
SHFM who carry specific chromosomal aberrations
involving chromosomal regions 7q22.1, 6q16.3-q22.3,
2q24-q31, and Xq24-q27, and these regions have been
considered to be candidate areas harboring genes that
lead to SHFM (Faiyaz ul Haque 1993; Scherer et al.
1994; Boles et al. 1995; Gurrieri et al. 1995). The results
of previous studies in families segregating SHFM as an
autosomal dominant trait established the presence of an
SHFM locus on 10q24-q25 (Nunes et al. 1995; Gurrieri
et al. 1996; Raas-Rothschild et al. 1996; O¨zen et al.
1999). We have also demonstrated the presence of at
least one additional autosomal locus, by the identifi-
cation of families with a dominant mode of inheritance
in whom there was failure to show linkage to 10q, 7q,
6q, or 2q (Gurrieri et al. 1996). To assess the potential
of p63, which is localized on 3q27, as a candidate gene
for SHFM, two multigenerational families in whom seg-
regation analysis had excluded linkage to all previously
identified autosomal regions were analyzed for the pres-
ence of p63 mutations (Gurrieri et al. 1996).
Material and Methods
Mutation Identification
Genomic DNA was isolated from peripheral blood
samples from family members, according to established
protocols. Blood samples were obtained after informed
consent was received. The study was approved by the
institutional review board of the University of Con-
necticut Health Center. Intronic primers were used to
specifically amplify fragments encompassing each of ex-
ons 5–8 from genomic DNA from each of the families.
The exon 5 primers, which produced a 284-bp fragment,
were TCTCCTTCCTTTCTCCACTGGC (S) and TGC-
CCACAGAATCTTGACCTTC (AS). The exon 6 prim-
ers, which produced a 259-bp fragment, were GCA-
CCAACATCCTGTTCATGC (S) and GTCTACTCA-
GTCCATAGAGGTGTTG (AS). The exon 7 primers,
which produced a 245-bp fragment, were GAAGGAAC-
AACGTCAGTTTAAACCC (S) and AAAGCAGCCAC-
GATTTCACTTTGCC (AS). The exon 8 primers, which
produced a 259-bp fragment, were GTGGTAGATCTT-
CAGGGGACTTTC (S) and CCAACATCAGGAGAA-
GGATTC (AS). The resulting PCR fragments were
screened for the presence of mutations by direct sequence
analysis using a PE Cycle Sequencing Kit (PE Biosys-
tems).
Segregation Analysis
For segregation analysis of the K194E mutation by
SSCP, the 284-bp PCR fragment encompassing exon
5 was analyzed on native polyacrylamide gels. DNA
fragments were mixed with a twofold excess of form-
amide-dye mix, were denatured for 2 min at 95C, and
were loaded onto a 10% polyacrylamide gel (39:1
acrylamide:bis-acrylamide ratio). Gels were run for 8 h
at 15 V/cm at 4C, and fragments were visualized by
silver staining.
For segregation analysis of the R280C mutation by
restriction-enzyme analysis, the 245-bp fragment en-
compassing exon 7 was subjected to digestion with the
restriction enzyme MspA1-I. PCR product (10 ml) was
diluted in 50 mM potassium acetate, 20 mM Tris-ace-
tate, 10 mM magnesium acetate, 1 mM dithiothreitol,
100 mg BSA (pH 7.9) per ml, and 10 U MspA1-I in a
total volume of 20 ml. After incubation for 5 h at 37C,
digestion products were analyzed by electrophoresis
through a 1.5% agarose gel.
Protein Modeling
A ribbon diagram of the p63 DNA-binding domain
was produced on the basis of the structure of its ho-
mologue, TP53. Amino acid residues 123–340 of the
p63 gene (GenBank accession number BAA32593),
which correspond to the DNA-binding domain of the
TP53 protein (Cho et al. 1994), were folded using a
modeling program (Lund et al. 1997). Manual docking
of the p63 structure was performed over theTP53DNA-
binding-domain structure by use of MOLMOL software
(Koradi et al. 1996).
Results
Clinical Phenotype
Both affected families weremembers of the Cape Prov-
ince mixed-ancestry population, with genetic endow-
ment from San, Khoi-Khoi, Javanese, indigenous Afri-
can, and European sources. Members of family R were
examined (by P.B.) during ascertainment in 1976. They
were reexamined in detail one decade later, and their
clinical manifestations were described and depicted
(Spranger and Schapera 1988). The spectrum of clinical
manifestations was broad, ranging from the presence of
a split hand in one individual to bilateral monodactyly
and unilateral aplasia of the right lower extremity with
a split left foot in another individual. Other family mem-
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Figure 1 A, Family R (left upper and lower panels). Note the “lobster-claw” anomaly of the hands and feet. Family A (right upper and
lower panels). Note the median clefts and syndactyly. B, Previously reported (Spranger and Schapera 1988) radiograph of family R (left). Note
monodactyly with triphalangeal thumb and duplication of the distal phalanx. Family A (center and right) shows absence of the phalanges of
the second and third digits in both foot and hand.
bers had variably split hands and feet with missing pha-
langes, metacarpals, and metatarsals, with or without
syndactyly and webbing (fig. 1). No family members had
any significant abnormalities other than those of the ex-
tremities. Individuals in family A were examined (by
P.B.) during the initial ascertainment in the 1970s, and
thereafter they were examined by clinical geneticists at
routine genetic clinics in Cape Province. Further clinical
appraisal was undertaken when blood specimens were
obtained for molecular studies. In 1999, thorough clin-
ical examinations of eight available family members (in-
dividuals II-1, III-7, III-9, IV-3, II-5, III-12, IV-5, and II-
7) were performed (by D.B.). The phenotypic expression
resembled that of family R and ranged from severe “lob-
ster-claw” malformations of the feet in individual II-7
to minor 3/4 syndactyly of the left foot appearing as the
only manifestation in individual III-14 (fig. 2). The
daughter of individual III-14 had distal duplications of
her thumbs bilaterally, with absence of the second and
third phalanges on the right hand and an absent second
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Figure 2 Extended pedigrees of family A (top) and family R (bottom). Individuals whose DNA was tested are indicated by an asterisk.
The phenotypic status of individuals in generations I and II of family R is unknown.
phalanx with 3/4 syndactyly of her left hand. No mem-
bers of either family had any significant abnormality of
the face, palate, skin, teeth, hair, or nails. No abnor-
malities of the mammary glands or nipples were noted,
and the matriarch confirmed that, to her knowledge,
none of her family members had any anomalies of this
type. Reduced penetrance was deduced in individual III-
17 (family A), who was a clinically normal female with
an affected parent and two affected offspring (fig. 2).
Similarly, in family R, individuals III-11 and III-18, who
were phenotypically normal, each had three affected off-
spring (fig. 2).
p63 Gene Mutations
Two missense mutations were identified in exons 5
and 7 in families R and A, respectively. These exons fall
within the DNA-binding domain of p63, which extends
from exons 4–8 (fig. 3A). In family R, the pointmutation
detected by DNA sequencing of two affected individuals
was 724ArG, which predicts amino acid substitution
K194E (fig. 3B). Similarly, in family A, the mutation
detected by DNA sequencing of two affected individuals
was 982TrC, which predicts amino acid substitution
R280C (fig. 3B). Neither mutation was detected in a
panel of 162 normal chromosomes derived from indi-
viduals of diverse ethnic origins, including European,
African, and Asian origins. SSCP analysis of DNA from
individuals in family R showed cosegregation of the mu-
tation with the SHFM phenotype (fig. 4A). Restriction-
endonuclease analysis of DNA from members of family
A also showed cosegregation of the mutation with the
phenotype (fig. 4B). Screening of the remaining p63 ex-
ons identified no additional sequence alterations in either
family A or family R (data not shown). The segregation
pattern of the mutations in the two families and their
absence from a panel of 81 unrelated normal individuals
(data not shown) strongly suggest their causal relation-
ship to the SHFM phenotype.
Mutation screening of the entire p63 coding sequence
in four families with the EEC syndrome revealed two
additional missense mutations. The clinical phenotype
of each family included median clefts of the extremi-
ties, cleft palate, and sparse hair without nipple and
breast anomalies. All four families with EEC syndrome
were of European origin. The mutations were a GrA
transition at nucleotide 980 in exon 7 that predicts an
arginine-to-histidine substitution at amino acid 279
(R279H) and a GrA transition at nucleotide 1065 in
exon 8 that predicts an arginine-to-glutamine substitu-
tion at amino acid 304 (R304Q) (data not shown). As
was the case for the SHFM p63 mutations described
above, neither the R279H mutation nor the R304Qmu-
tation was detected in a panel of 162 normal chromo-
somes derived from individuals of diverse ethnic origins.
p63 Protein Modeling
All four of these p63 mutations are in the DNA-bind-
ing domain of the molecule. The possible consequences
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Figure 3 A, Schematic representation of exons 4–8 of the p63 gene, the region that contains the DNA-binding domain. Exons 4–8 were
amplified individually from genomic DNA samples, and the resulting fragments were analyzed by means of direct sequence analysis. The K194E
and R280C mutations, present in exons 5 and 7, respectively, are shown in comparison with the wild-type sequence. B, Identification of the
K194E and R280C mutations in individuals with SHFM. The individual with the K194E mutation is heterozygous A/G at nucleotide 724,
compared with the normal individual, who is homozygous A at this position. The individual with the R280C mutation is heterozygous T/C at
nucleotide 982, compared with the normal individual, who is homozygous C at this position.
of the mutations were assessed by building a model of
the DNA-binding domain of the p63 protein on the basis
of the structure of its homologue, TP53, for which the
crystal structure has been solved (Cho et al. 1994). Ac-
cording to this model, it can be deduced that the p63
DNA-binding domain assumes a loop-sheet-helix motif
and two large loops that make up the DNA-binding
surface of the protein (Pavletich et al. 1993; Cho et al.
1994) (fig. 5).
Discussion
The p63 amino acids reported herein to be mutated in
two families with SHFM are the arginine at position 280
and the lysine at position 194 (fig. 5). The arginine at
position 280 is conserved in all three homologues (TP53,
p63, and TP73). This amino acid residue occurs in the
L3 loop, and it is surrounded by portions of the L2 and
L3 loops and the COOH-terminal end of the S3 strand
from the b sandwich. The lysine at position 194 is con-
served in TP73 but not in TP53. Remarkably, on the
basis of the p63 model structure, although the arginine
at position 280 and the lysine at position 194 are sep-
arated by ∼100 amino acid residues, these two amino
acids reside adjacent to each other in the protein-DNA
complex. Rather than directly interacting with the DNA,
these two residues primarily appear to be involved in
maintenance of the overall structure of the domain. For
example, the arginine at position 280 interacts with a
number of other amino acids and forms a salt bridge
with the carboxylate of the glutamic acid at position
200 (Cho et al. 1994).
In contrast, the two p63mutations that we have iden-
tified in individuals affected with EEC syndrome reside
in amino acids that are directly involved in DNA bind-
ing. The arginine at position 279, for example, reaches
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Figure 4 A, Segregation of the K194E mutation in family R.
The presence of the K194E mutation was detected by SSCP analysis
of a 284-bp PCR fragment encompassing exon 5. Normal individuals
show two bands corresponding to the two DNA strands, whereas
affected individuals show two doublets corresponding to the mutant
and normal DNA strands. B, Segregation of the R280C mutation in
family A. The presence of the R280C mutation was detected by its
creation of a CCGCTG recognition site for the restriction enzyme
MspA1-I. Digestion of a 245-bp PCR fragment encompassing exon 7
produces subfragments of 138 bp and 107 bp, in addition to the un-
digested 245-bp fragment, in affected individuals. In normal individ-
uals, only the full-length 245-bp fragment is seen. In both cases, the
mutation segregated with the disease in all family members tested. A
representative section of each family is shown.
Figure 5 Ribbon diagram of the p63 DNA-binding domain,
based on the structure of its homologue, p53. The narrow arrowheads
denote side chains of the amino acid residues mutated in SHFM (K194
and R280 [red]), and the broad arrowheads denote residues mutated
in EEC (R279 and R304 [green]).
into the minor groove of the DNA, where it interacts
with the A-T–rich region of the consensus sequence that
is required for specific DNA recognition (Cho et al.
1994). The second amino acid that we have found to
be mutated in EEC syndrome, the arginine at position
304, directly contacts a phosphate in the backbone of
the DNA. In an earlier study (Celli et al. 1999), mu-
tations in the arginine residue at position 279 as well
as mutations of the serine at position 272 have also
been identified. The serine at position 272 forms a hy-
drogen bond with a phosphate in the DNA backbone.
Thus, the mutations responsible for EEC syndrome re-
side in amino acid residues that directly interact with
the DNA, in contrast to mutations that we have iden-
tified in nonsyndromic SHFM, which reside in amino
acid residues that appear to be indirectly involved in
DNA binding. It is tempting to speculate that the phe-
notypic distinction between SHFM and EEC syndrome
arises as a consequence of this difference.
The p63 gene differs from its TP53 homologue in
that it expresses at least six major transcripts (Yang et
al. 1998). Three of these transcripts encode proteins
with transactivation, DNA-binding, and oligomeriza-
tion domains similar to those of TP53, whereas three
lack the N-terminal domain required for transcriptional
activation. It has therefore been suggested that p63 pro-
teins be divided into two classes, one with TP53-like
properties and the other without TP53-associated func-
tions such as transcriptional activation and regulation
of apoptosis. Interestingly, it appears that some p63
isotypes can act as dominant-negative inhibitors of
TP53 and p63 activation, suggesting a pathogenetic
mechanism for the observed heterozygous mutations in
patients with SHFM or EEC syndrome (Yang et al.
1998). The apparently opposing properties of the var-
ious p63 isotypes open the possibility of both prolif-
erative and growth-suppressing pathways involving
p63. It will be of great interest to determine the role of
the various p63 isotypes in the developing limb.
The AER forms in response to signals from limb mes-
oderm and, in turn, controls the production of a factor
in limb mesoderm that feeds back to the AER, main-
taining it in an active and functional state. Interference
with AER maintenance has been suggested to be the
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general pathway affected in SHFM. Thus, the fact that
mutations in p63 result in SHFM suggests that p63may
also be involved in maintenance of AER activity as well
as in formation of the AER. In recent studies of ho-
mozygous Dac mice (Ianakiev et al. 1999; Sidow et al.
1999), dactylin, a member of the WD40/F-box family,
has been identified as another molecule involved in
maintenance of the AER.
In conclusion, we have demonstrated that mutations
in the p63 gene, a homologue of the archetypal tumor
suppressor TP53 with the potential to be involved in
both proliferative and growth-suppressing pathways,
cause SHFM. SHFM and the EEC syndrome could be
considered to be p63 morphopathies (Radhakrishna et
al. 1999). It remains to be clarified why mutations in
the p63 gene are sometimes associated with nonsyn-
dromic SHFM, as our findings indicate, and, at other
times, are linked to EEC syndrome, as reported.
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